260 related articles for article (PubMed ID: 9719378)
1. Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.
Passos-Bueno MR; Richieri-Costa A; Sertié AL; Kneppers A
J Med Genet; 1998 Aug; 35(8):677-9. PubMed ID: 9719378
[TBL] [Abstract][Full Text] [Related]
2. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
[TBL] [Abstract][Full Text] [Related]
3. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
[TBL] [Abstract][Full Text] [Related]
4. Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.
Sakai N; Tokunaga K; Yamazaki Y; Shida H; Sakata Y; Susami T; Nakakita N; Takato T; Uchinuma E
J Craniofac Surg; 2001 Nov; 12(6):580-5. PubMed ID: 11711827
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.
Oldridge M; Lunt PW; Zackai EH; McDonald-McGinn DM; Muenke M; Moloney DM; Twigg SR; Heath JK; Howard TD; Hoganson G; Gagnon DM; Jabs EW; Wilkie AO
Hum Mol Genet; 1997 Jan; 6(1):137-43. PubMed ID: 9002682
[TBL] [Abstract][Full Text] [Related]
6. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery.
von Gernet S; Golla A; Ehrenfels Y; Schuffenhauer S; Fairley JD
Clin Genet; 2000 Feb; 57(2):137-9. PubMed ID: 10735635
[TBL] [Abstract][Full Text] [Related]
8. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome.
Matsumoto K; Urano Y; Kubo Y; Nakanishi H; Arase S
Plast Reconstr Surg; 1998 Feb; 101(2):307-11. PubMed ID: 9462761
[TBL] [Abstract][Full Text] [Related]
10. Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders.
Tartaglia M; Di Rocco C; Lajeunie E; Valeri S; Velardi F; Battaglia PA
Hum Genet; 1997 Nov; 101(1):47-50. PubMed ID: 9385368
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 mutations among Thai children with Crouzon and Apert syndromes.
Shotelersuk V; Mahatumarat C; Ittiwut C; Rojvachiranonda N; Srivuthana S; Wacharasindhu S; Tongkobpetch S
J Craniofac Surg; 2003 Jan; 14(1):101-4; discussion 105-7. PubMed ID: 12544231
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
[TBL] [Abstract][Full Text] [Related]
13. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.
Wilkie AO; Slaney SF; Oldridge M; Poole MD; Ashworth GJ; Hockley AD; Hayward RD; David DJ; Pulleyn LJ; Rutland P
Nat Genet; 1995 Feb; 9(2):165-72. PubMed ID: 7719344
[TBL] [Abstract][Full Text] [Related]
14. Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III.
Gripp KW; Stolle CA; McDonald-McGinn DM; Markowitz RI; Bartlett SP; Katowitz JA; Muenke M; Zackai EH
Am J Med Genet; 1998 Jul; 78(4):356-60. PubMed ID: 9714439
[TBL] [Abstract][Full Text] [Related]
15. The appearance of the feet in Pfeiffer syndrome caused by FGFR1 P252R mutation.
Rossi M; Jones RL; Norbury G; Bloch-Zupan A; Winter RM
Clin Dysmorphol; 2003 Oct; 12(4):269-74. PubMed ID: 14564217
[TBL] [Abstract][Full Text] [Related]
16. Clinical variability in patients with Apert's syndrome.
Lajeunie E; Cameron R; El Ghouzzi V; de Parseval N; Journeau P; Gonzales M; Delezoide AL; Bonaventure J; Le Merrer M; Renier D
J Neurosurg; 1999 Mar; 90(3):443-7. PubMed ID: 10067911
[TBL] [Abstract][Full Text] [Related]
17. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.
Rutland P; Pulleyn LJ; Reardon W; Baraitser M; Hayward R; Jones B; Malcolm S; Winter RM; Oldridge M; Slaney SF
Nat Genet; 1995 Feb; 9(2):173-6. PubMed ID: 7719345
[TBL] [Abstract][Full Text] [Related]
18. Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome.
Tartaglia M; Valeri S; Velardi F; Di Rocco C; Battaglia PA
Hum Genet; 1997 May; 99(5):602-6. PubMed ID: 9150725
[TBL] [Abstract][Full Text] [Related]
19. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.
Oldridge M; Zackai EH; McDonald-McGinn DM; Iseki S; Morriss-Kay GM; Twigg SR; Johnson D; Wall SA; Jiang W; Theda C; Jabs EW; Wilkie AO
Am J Hum Genet; 1999 Feb; 64(2):446-61. PubMed ID: 9973282
[TBL] [Abstract][Full Text] [Related]
20. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.
Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K
Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
